Browsing by Author Giobbie-Hurder, Anita

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 11 of 11
Issue DateTitleAuthor(s)Citation
2015Adjuvant ovarian suppression in premenopausal breast cancerCoates, Alan; Bellet, Meritxell; Bonnefoi, Herve; Buchholz, Stefan; Burstein, Harold; Ciruelos, Eva; Climent, Miguel; Coleman, Richard; Colleoni, Marco; Da Prada, Gian; Davidson, Nancy; Fleming, Gini; Francis, Prudence; Gelber, Richard D. (Prof); Geyer, Charles; Giobbie-Hurder, Anita; Goldhirsch, Aron (Prof); Ingle, J.; Kerbrat, Pierre; Lang, Istvan; Maibach, Rudolph; Martino, Silvana; Price, K. N; Rabaglio-Poretti, Manuela; Regan, Meredith; Ruepp, Barbara; Viale, Giuseppe; Walley, Barbara; Winer, EP; School of Public Health: Public HealthAdjuvant ovarian suppression in premenopausal breast cancer, The New England Journal of Medicine, vol.372, 5, 2015,pp 436-446
2010Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer.Coates, Alan; Castiglione-Gertsch, Monica; Colleoni, Marco; et al, various; Giobbie-Hurder, Anita; Gusterson,, B; Maiorano, Eugenio; Mallon, Elizabeth; Mastropasqua, Mauro G.; Sonzogni, A; Viale, Giuseppe; School of Public Health: Public HealthAdverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer., Annals of Oncology, vol.21, 2,pp 245-254
2011Analyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 studyCoates, Alan; Chirgwin, Jacquie H; Colleoni, Marco; Forbes, John F.; Gelber, Richard D. (Prof); Giobbie-Hurder, Anita; Goldhirsch, Aron (Prof); Lang, Istvan; Mauriac, L; Mouridsen, Henning; Paridaens, R.J.; Pienkowski, Tadeusz; Price, Karen N.; Regan, Meredith M.; Smith, Ian (Prof); Thurlimann, Beat; Wardley, Andrew; School of Public Health: Public HealthAnalyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 study, Journal of Clinical Oncology, vol.29, 9, 2011,pp 1117-1124
2011Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8.1 years median follow-upCoates, Alan; Ejlertsen, Bent; Forbes, John F.; Gelber, Richard; Giobbie-Hurder, Anita; Goldhirsch, Aron; Lang, Istvan; Mauriac, Louis; Neven, Patrick; Price, Karen N.; Rabaglio, Manuela; Regan, Meredith M.; Smith, Ian (Prof); Thurlimann, B.; Wardley, Andrew; School of Public Health: Public HealthAssessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8.1 years median follow-up, Lancet Oncology, vol.12, 12, 2011,pp 1101-1108
2017Cholesterol, cholesterol-lowering medication use, and breast cancer outcome in the BIG 1-98 studyCoates, Alan; Ahern, T; Borgquist, Signe; Colleoni, Marco; Debled, Marc; Ejlertsen, Bent; et al, Various; Garber, Judy; Giobbie-Hurder, Anita; Lang, Istvan; von Moos, Roger; NH&MRC Clinical Trials CentreCholesterol, cholesterol-lowering medication use, and breast cancer outcome in the BIG 1-98 study, Journal of Clinical Oncology, vol.35, 11, 2017,pp 1179-1188
2009Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer.Coates, Alan; et al, various; Forbes, John F.; Giobbie-Hurder, Anita; Goldhirsch, Aron; Mauriac, Louis; Mouridsen, Henning; Paridaens, Robert; Price, Karen; Smith, Ian (Prof); Thurlimann, Beat; School of Public Health: Public HealthLetrozole therapy alone or in sequence with tamoxifen in women with breast cancer., New England Journal of Medicine, vol.361, 8,pp 766-776
2015Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trialCoates, Alan; Bibeau, Frederic; Ejlertsen, Bent; et al, Various; Giobbie-Hurder, Anita; Gusterson, Barry A; Lelkaitis, Gierdrius; MacGrogan, G.; Mallon, Elizabeth; Munzone, Elisabetta; Thurlimann, B.; Viale, Giuseppe; School of Public Health: Public HealthOutcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial, Annals of Oncology, vol.26, 12, 2015,pp 2442-2449
2008Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With LetrozoleCoates, Alan; Braye, Stephen; Dell'Orto, Patrizia; et al, Various; Giobbie-Hurder, Anita; MacGrogan, Gaetan; Maiorano, Eugenio; Mastropasqua, Mauro G.; Ohlschlegel, Christian; Regan, Meredith M.; Viale, Giuseppe; School of Public Health: Public HealthPrognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole, Journal of Clinical Oncology, vol.26, 34, 2008,pp 5569-5575
2015Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 TrialCoates, Alan; Colleoni, Marco; Debled, Marc; Ejlertsen, Bent; Filho, Otto Metzger; Gelber, Richard; Giobbie-Hurder, Anita; Goldhirsch, Aron; Gusterson, B. A.; Mallon, Elizabeth; Price, Karen N; Regan, Meredith; Thurlimann, Beat; Viale, Giuseppe; Winer, Eric P.; School of Public Health: Public HealthRelative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial, Journal of Clinical Oncology, vol.33, 25, 2015,pp 2772-2779
2014Symptoms of endocrine treatment and outcome in the BIG 1-98 studyCoates, Alan; Bonnefoi, Herve; Cole, B F; Ejlertsen, Bent; et al, Various; Forbes, John F.; Giobbie-Hurder, Anita; Huober, J; Lang, Istvan; Neven, Patrick; Rabaglio, Manuela; Wu, Junru; School of Public Health: Public HealthSymptoms of endocrine treatment and outcome in the BIG 1-98 study, Breast Cancer Research and Treatment, vol.143, 1, 2014,pp 159-169
2016Treatment adherence and its impact on disease-free survival in the breast international group 1-98 trial of tamoxifen and letrozole, alone and in sequenceCoates, Alan; Chirgwin, Jacquie; Debled, Marc; Ejlertsen, Bent; et al, Various; Gelber, Richard D; Giobbie-Hurder, Anita; Goldhirsch, Aron; Price, Karen N.; Rabaglio, Manuela; Smith, Ian; School of Public Health: Public HealthTreatment adherence and its impact on disease-free survival in the breast international group 1-98 trial of tamoxifen and letrozole, alone and in sequence, Journal of Clinical Oncology, vol.34, 21, 2016,pp 2452-2459